Статья освещает проблемы методического и методологического порядка при использовании наиболее распространенных эхокардиографических методов вычисления массы миокарда левого желудочка по линейным размерам у лиц с артериальной гипертонией, а так же различных вариантов её индексации для диагностики гипертрофии миокарда левого желудочка, за которыми скрываются многочисленные факторы воздействия на вес миокарда в разных возрастных группах. В статье приведены множественные критерии гипертрофии миокарда левого желудочка даже в пределах одной индексации, затрудняющие интерпретацию полученных результатов Возможным методом поиска оптимальной формулы расчёта массы миокарда левого желудочка и его стандартизации является изучение взаимосвязей структурных параметров левого желудочка с его систолической, диастолической функцией и многочисленными показателями структурно-функциональной перестройкой сосудистой системы при артериальной гипертонии. Приведены аргументации использования методики Реnn Соnvention cо стандартизацией к площади поверхности тела.
The article deals with the matter of methodical and methodological procedure in the most common echocardiographic methods for calculating of left ventricular mass in linear measurements in patients with hypertension, as well as various options for its indexing for the diagnosis of left ventricular hypertrophy, where many factors may impact on the weight of the myocardium in different age groups. Multiple criteria for left ventricular hypertrophy are present even within a single indexing, complicating interpretation of the results. Learning the relationship of the structural parameters of the left ventricle with systolic, diastolic function, and numerous indicators of structural and functional changes of the vascular system in arterial hypertension might be possible way for finding an optimal formula for calculating left ventricular mass and standardization. Reasoning for use of Penn Convention method with standardization to body surface area is given.
1. Беленков Ю.Н., Терновой С.К., Синицын В.Е. Магнитно-резонансная томография сердца и сосудов // Москва, Видар, 1997.
2. Профилактика, диагностика и лечение первичной артериальной гипертонии в Российской Федерации. Первый Доклад экспертов научного общества по изучению артериальной гипертонии Всероссийского научного общества кардиологов и Межведомственного совета по сердечно-сосудистым заболеваниям (ДАГ-I). Клиническая фармакология и терапия 2000; 3: 5-30.
3. Рафиков А.Ю., Галявич А.С. Сравнительный анализ данных эхокардиографии (ЭХО-КГ) и мультиспиральной компьютерной томографии (МСКТ) в оценке функциональных параметров левого желудочка у пациентов с гипертонической болезнью (ГБ). Казанский медицинский журнал, 2012.-N 6.-С.855-858.
4. Рекомендации по лечению артериальной гипертонии ESH/ESC 2013. Российский кардиологический журнал. 2014; 1: 7-94.
5. Шмидт-Ниельсен К. Размеры животных: почему они так важны?: Пер. с англ. - М.: Мир, 1987. - 259 с.
6. Abergel E., Tase M., Bohlader J. Which definition for echocar-diographic left ventricular hypertrophy? Am J Cardiol 1995;75:489-503.
7. Antoniucci D., Seccareccia F., Menotti A. et al. Prevalence and correlates of echocardiographic determined left ventricular hypertrophy in 2318 asymptomatic middle-aged men: the ECCIS project. Epidemiolgia e Clinica della Cardiopatia Ischemica Silente // J. Ital. Cardiology. - 1997. - Vol. 27, № 4. - P. 363-369.
8. Burke GL, Arcilla RA, Culpepper WS, Wehber LS, Chiang YK, Berenson GS. Blood pressure and echocardiographic measures in children: the Bogalusa. Heart Study. Circulation 1987;75:10%14.
9. Casale P.N., Devereux R.B., Milner M. et al. Value of echocardiographic measurement of left ventriculsr mass in predicting cardiovascular morbid events in hypertensive men. Ann. Intern. Med. 1986; 105: 173-178.
10. Daniels SD, Meyer RA, Loggie LMH. Determinants of cardiac involvement in children and adolescents with essential hypertension. Circulation 1990;82:1243-8.
11. De Simone G, Devereux RB, Daniels SR, Koren MJ, Alderman MH, Laragh JH. Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and of their capacity to predict cardiovascular risk. J Am Coll Cardiol. 1995;25:1056-1062.
12. De Simone G, Devereux RB, Roman M J, et al. Gender-differences in left ventricular anatomy, blood viscosity and volume regulatory hormones in normal adults. Am J Cardiol 1991;68:1704-8.
13. De Simone G., Devereux R.B., Roman M.J. et al. Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults // Hypertension. - 1994. - Vol. 23. - P. 600-606.
14. De Simone G1, Devereux RB, Kimball TR, Mureddu GF, Roman MJ, Contaldo F, Daniels SR. Interaction between body size and cardiac workload: influence on left ventricular mass during body growth and adulthood. Hypertension. 1998 May;31(5):1077-82.
15. De Simone G1, Verdecchia P, Pede S, Gorini M, Maggioni AP. Prognosis of inappropriate left ventricular mass in hypertension: the MAVI Study. Hypertension. 2002 Oct;40(4):470-6.
16. Devereux R.B., Reichek N. Echocardiographic determination of left ventricular mass in man: Anatomic validation of the method. Circulation 1977; 55: 613-618.
17. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986. 57:450-458.
18. Gardin JM, Lauer MS. Left ventricular hypertrophy: the next treatable, silent killer?JAMA.2004;292:2396-2398.
19. Ghali J.K., Liao Y., Simmons B. et al. The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease // Ann. Intern. Med. - 1992. - Vol. 117. - P. 831-836.
20. Gidding SS. Controversies in the assessment of left ventricular mass. Hypertension. 2010 Jul;56(1):26-8.
21. Gosse P., Jullien V., Jarnier P. et al. Echocardiographic definition of left ventricular hypertrophy in the hypertensive: which method of indexation of left ventricular mass? // J. Hum. Hypertension. - 1999. - Vol. 13, № 8. - P. 505-509.
22. Hammond I.W., Devereux R.B., Alderman M.H. et al. The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension // J. Amer. Coll. Cardiology. - 1986. - Vol. 7. - P. 639-650.
23. Hurst's the heart / Eds. V. Fuster, R.W. Alexander, R.A. O'Rourke et al. - 10th ed. - 2001. - Vol. 1. - 1488 p.
24. Ilercil A, O'Grady MJ, Roman MJ, Paranicas M, Lee ET, Welty TK, et al. Reference values for echocardiographic measurements in urban and rural populations of differing ethnicity: the Strong Heart Study. J Am Soc Echocardiogr 2001; 14:601-11.
25. Koren M.J., Devereux R.B., Casale P.N., Savage D.D., Laragh J.H. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med. 1991 Mar 1;114(5):345-52. doi:10.7326/0003-4819-114-5-345.
26. Lang R.M., Bierig M., Devereux R.B., Flachskampf F.A., Foster E., Pellikka P.A. et al. Recommendations for chamber quantification: A report from the American Society of echocardiography's Guidelines and Standards committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of echocardiography, a branch of the European Society of cardiology. J Am Soc Echocardiogr 2005;18:1440-63.
27. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA at al. Recommendations for chamber quantification. Eur J Echocardiogr. 2006 Mar;7(2):79-108.
28. Levy D., Garrison R.J., Savage D.D. et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study // New Engl. J. Med. - 1990. - Vol. 322. - P. 1561-1566.
29. Levy D., Savage D.D., Garrison R.J., Anderson K.M., Kannel W.B., Castelli W.P. Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol. 1987 Apr 15;59(9):956-60.
30. Liao Y., Cooper R.S., Durazo-Arvizu R. et al. Prediction of mortality risk by different methods of indexation for left ventricular mass // J. Amer. Coll. Cardiology. - 1997. - Vol. 29, № 3. - P. 641-647.
31. Linzbach AJ. Hypertrophy, hyperplasia and structural dilatation of the human heart. Adv Cardiol 1976;18:1-14.
32. Mahn J.J., Dubey E., Brody A., Welch R., Zalenski R., Flack J.M., Ference B., Levy P.D. Test characteristics of electrocardiography for detection of left ventricular hypertrophy in asymptomatic emergency department patients with hypertension. Acad Emerg Med. 2014 Sep;21(9):996-1002. doi: 10.1111/acem.12462.
33. Mahoney LT, Schieken RM, Clarke WR, Lauer RM. Left ventricular mass and exercise responses predict future bkmd pressure. Hypertension 1988112:206-13.
34. Mureddu GF, Pasanisi F, Palmieri V, Celentano A, Contaldo F, de Simone G. Appropriate or inappropriate left ventricular масса in the presence or absence of prognostically adverse left ventricular hypertrophy. J Hypertens. 2001; 19: 1113-1119.
35. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.Pediatrics.2004;114:555-576.
36. Schiller N.B., Shah P.M., Crawford M. et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography committee on standards, subcommittee on quantitation of two-dimensional echocardiograms // J. Amer. Soc. Echocardiography. - 1989. -Vol. 2. - P. 358-367.
37. Troy B.L., Pombo J., Rackley C.E.Measurement of left ventricular wall thickness and mass by echocardiography // Circulation. 1972. Vol. 45. P. 602-611.
38. Verhaaren HA, Schieken RM, Mosteller M, Hewitt JK, Eaves LJ, Nanee WE. Bivariate genetic analysis of left ventricular mass and weight in pubertal twins (the Medical College of Virginia Twin study). Am J Cardiol 199l;68:661-8.11-14.